Clinical Trial Details
EORTC-1532-GUCG
Back to Clinical Trials Database
A phase 2 Randomized Open-Label Study of Oral darolutamide (ODM-201) vs. androgen deprivation therapy (ADT) with LHRH agonists or antagonist in Men with Hormone Naive Prostate Cancer
Trial Status | Closed to Patient Entry |
---|---|
Dates |
Date of activation: 01-Dec-2017 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 250 - All Groups: 250 |
Treatment |
Drug Goserelin, Triptorelin, Leuprorelin, Degarelix, ODM-201 |
Study Staff |
Bertrand Tombal (Study Coordinator) , Cliniques Universitaires Saint-Luc, Brussels Hazal Erkol (Data Manager) , EORTC Headquarters, Brussels Catherine Fortpied (Statistician) , EORTC Headquarters, Brussels Beatrice Fournier (Clinical Scientist) , EORTC Headquarters, Brussels Claire Gandilhon (Clinical Operations Assistant) , EORTC Headquarters, Brussels Amaya Gonzalez (Clinical Research Associate/Monitor) , EORTC Headquarters, Brussels Joanna Krzystyniak (Clinical Operations Manager) , EORTC Headquarters, Brussels Belma Malanda (Project Manager) , EORTC Headquarters, Brussels Barbara Ogrodniczak (Junior Clinical Operations Manager) , , Miguel Remis (Lead CRA) , EORTC Headquarters, Brussels Lucy Sepulveda (Regulatory Affairs Administrator) , EORTC Headquarters, Brussels Jelle Stans (Regulatory Affairs Manager) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels Gaetan de Schaetzen (Senior Clinical Operations Manager) , EORTC Headquarters, Brussels |
Type of cancer | Prostate |
Participating groups |
EORTC Genito-Urinary Cancers Group DEUTSCHE URO-ONKOLOGEN E.V. |
Recruiting centers |
Azienda Ospedaliera Città della Salute e della Scienza di Torino - Ospedale Molinette (Torino, Italy) CHU Mont Godinne - UCL Namur (Yvoir, Belgium) CHU de Limoges - Hopital Dupuytren (LIMOGES CEDEX 1, France) Centre Georges-Francois-Leclerc (DIJON CEDEX, France) Cliniques Universitaires Saint-Luc (Brussels, Belgium) Fundacion Instituto Valenciano De Oncologia (Valencia, Spain) Gustave Roussy (VILLEJUIF CEDEX, France) Hopital Universitaires Erasme (Brussels, Belgium) Hospital Universitario Ramon y Cajal (Madrid, Spain) Hospital Universitario Virgen De La Victoria (Malaga, Spain) Hospital Universitario de Salamanca - Hosp Virgen De la Vega (Salamanca, Spain) ICO Badalona - Hospital Germans Trias i Pujol (Institut Catala D'Oncologia) (Badalona - (Barcelona), Spain) National Cancer Institute - Cairo (Cairo, Egypt) Universitair Ziekenhuis Gent (Gent, Belgium) |
Protocol summary | http://clinicaltrials.gov/study/NCT02972060 |
NCT number | NCT02972060 |
EudraCT | 2016-004334-17 |
Financial Support | Educational Grant |